Organization
Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
12 abstracts
Abstract
Shareable artificial intelligence to extract cancer outcomes from electronic health records.Org: Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Memorial Sloan Kettering Cancer Center, New York, NY, USA, Dana-Farber Cancer Institute, Boston, MA, USA, Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Memorial Sloan Kettering Cancer Center, New York, NY, Dana-Farber Cancer Institute, Boston, MA, Dana-Farber Cancer Institute,
Abstract
Changing treatment patterns for hepatocellular carcinoma: A SEER-Medicare study.Org: Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Dana Farber Cancer Institute, Boston, MA, Dana-Farber Cancer Institute, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Abstract
Racial differences in the utilization of MRI-guided biopsy before prostate cancer diagnosis.Org: Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Sidney Kimmel Medical College of Thomas Jefferson University, Sidney Kimmel Cancer Center at Jefferson Health, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA,
Abstract
Are enrollment criteria for phase II and III clinical trials in acute myeloid leukemia arbitrarily restrictive?Org: Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Dana-Farber Cancer Institute,
Abstract
Enzalutamide vs abiraterone in patients with prostate cancer with and without type 2 diabetes mellitus.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Thomas Jefferson University, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, College of Computing and Informatics,
Abstract
Interactive music therapy for chronic pain management in people with advanced cancer: A mechanistic study.Org: Drexel University, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University,
Abstract
Disparities in uptake of novel therapies for acute myeloid leukemia.Org: Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Dana-Farber Cancer Institute,
Abstract
Preliminary outcomes of a financial navigation program among lower socioeconomic patients with cancer.Org: School of Social Policy & Practice, University of Pennsylvania, Sidney Kimmel Cancer Center at Thomas Jefferson University, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA,
Abstract
A novel program to address acute food insecurity among patients with cancer in Philadelphia.Org: Legacy of Hope, Philadelphia, PA, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center at Thomas Jefferson University, Sidney Kimmel Medical College at Thomas Jefferson University,
Abstract
A comprehensive assessment of social determinants of health for metastatic breast cancer.Org: Sidney Kimmel Cancer Center at Thomas Jefferson University, Thomas Jefferson University, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University,
Abstract
Technology-enhanced acceleration of germline evaluation for therapy (TARGET): Results of a randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.Org: Yale Cancer Center, Yale School of Medicine, New Haven, CT, Yale School of Medicine, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University,
Abstract
The impact of music therapy on opioid use in cancer survivors with chronic pain.Org: Drexel University, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University,